D-0129-2026 Class II Ongoing

Recalled by FARMAKEIO OUTSOURCING LLC — Southlake, TX

FDA drug recall D-0129-2026 was initiated by FARMAKEIO OUTSOURCING LLC on Oct 14, 2025 and is designated Class II. Reason for recall: CGMP Deviations: Potential presence of metal particulate matter The recall status is ongoing. Affected quantity: 14,329 pellets.

Recall details

Product Type
Drugs
Report Date
Nov 5, 2025
Initiation Date
Oct 14, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,329 pellets

Product description

Testosterone Regular Release 200 MG, 1 PELLET (STERILE) FOR SUBCUTANEOUS INSERTION, RX ONLY, FarmaKeio Outsourcing, 920 S Kimball Ave, Ste 100, Southlake, TX 76092. NDC 73693-0402-01

Reason for recall

CGMP Deviations: Potential presence of metal particulate matter

Distribution pattern

Nationwide in the USA and Antigua

Code information

Lot, expiry: 3201, Exp 2/7/2026; 3202, Exp 2/21/2026; 3280, Exp 4/8/2026; 3283, Exp /9/2026.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0129-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0129-2026. Report a data issue: hello@regdatalab.com.